InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,140.00
(
0.47%
)
Dow Jones
39,357.01
(
0.00%
)
Brent Oil
81.47
(
-0.17%
)
Bitcoin
58,883.25
(
-0.80%
)
Post# of 252864
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 835
Posts 120262
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: investorgold2002 post# 120040

Sunday, 05/15/2011 6:27:19 PM

Sunday, May 15, 2011 6:27:19 PM

Post# of 252864

Wouldn't innovator companies patent both product and processes for making em when they file for new drug ? so they are disclosing IP to competitors…

Pharmaceutical manufacturing processes are generally protected by trade secrets rather than patents. (Note that the FDA’s Orange Book for small-molecule drugs prohibits inclusion of process patents.)

“The notion that there’s a Chinese Wall between sell-side analysts
and investment bankers may be the second-biggest piece of BS
ever promulgated in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up